- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Merck & Co Inc
+ Add to WatchlistMRK:US
46.7100 USD 0.6200 1.31%
Share
As of 20:04:01 ET on 05/22/2013.
More on MRK
News for Merck & Co Inc (MRK)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Merck Insomnia Drug Safe Only in Lower Doses, Panel Says
- Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
- Merck to Buy Back $5 Billion of Its Shares From Goldman
- Merck Insomnia Drug Safer at Lower Dose, FDA Staff Says
- Credit Swaps in U.S. Fall as Leading Indicators, Sentiment Rise
- Petrobras, Merck Lead $54 Billion of Company Bond Sales in U.S.
- Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
- U.S. Stock Options With Biggest Changes in Implied Volatility
- BlackRock Has Alternative to Money Funds: Credit Markets
- AmEx, Merck Lead $16.5 Billion of Company Bond Issuance in U.S.
- Merck Plans $6.5 Billion Bond Offering for Stock Repurchases
- Merck KGaA Profit Beats Estimates on Cost-Cutting
- Human Immune-Boosting Cancer Drugs Seen Extending Lives
- Adcock Takeover May Value Company at $1.5 Billion, JPMorgan Says
- Merck, Glaxo Reduce HPV Vaccine Prices in Poorest Regions
- Merck Statement on FDA Advisory Committee Meeting for Suvorexant Published 11 hours ago
- Merck Announces $5 Billion Accelerated Share Repurchase Published May 21, 2013
- Merck to Present at the UBS Global Healthcare Conference Published May 17, 2013
- Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Published May 17, 2013
- Fitch Rates Merck & Co.'s Proposed Debt 'A+' Published May 16, 2013
- Merck Prices $ 6.5 Billion Debt Offering Published May 15, 2013
- Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference Published May 14, 2013
- VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors Published May 13, 2013
- Sanford Heisler Files $100m+ Discrimination Suit Against Pharma Giant Merck & Co., Inc. Published May 09, 2013
- GARDASIL® Available to Developing Countries through UNICEF Tender Published May 09, 2013
- GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available Published May 09, 2013
- Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Published May 08, 2013
- Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management Published May 07, 2013
- Merck Consumer Care Launches Health and Wellness Effort To Help Empower Moms To Live A More Active Lifestyle With Their Published May 06, 2013
- ADDING MULTIMEDIA: FDA Approves Merck’s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Published May 06, 2013
- Emerging Stocks Head for Biggest Drop in 10 Months Updated 1 hour ago
- Ranbaxy Slumps After Daiichi Seeks ’Legal Remedy’: Mumbai Mover Updated 3 hours ago
- Merck Insomnia Drug Safe Only in Lower Doses, Panel Says
- U.S. Stocks Fall on Concern Fed Will Scale Back Stimulus
- Pfizer to Split Off Rest of Zoetis Animal Health Business
- BioMarin Gains on Prospects for Experimental Cancer Drug
- New Flu Vaccine Beats Current Products in Animal Testing
- Europe Stocks Little Changed as Bernanke Backs Bond Plan
- Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
- Hedge Funds Trail S&P 500 by 10 Percentage Points, Goldman Says
- India Said to Seek Review of U.S. Court Ruling Papers on Ranbaxy
- Swiss Billionaires Buy Merck Geneva Building for Biotech Campus
- The Top Ten Stocks for Wednesday, May 22
- Apple Got No Sweetheart Accord on Corporate Tax Bill, Irish Say
- Glaxo to Get Up to $200 Million for U.S. Research
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page